We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+13.04%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
–
AUM
$6.86B
AUM Growth
-$3.41B
Cap. Flow
-$3.78B
Cap. Flow %
-55.19%
Top 10 Hldgs %
25.96%
Holding
2,871
New
973
Increased
552
Reduced
524
Closed
811

Top Buys

Rank Stock Value
1
IWD icon
iShares Russell 1000 Value ETF
IWD
+$48M
2
AEP icon
American Electric Power
AEP
+$40.9M
3
CMCSA icon
Comcast
CMCSA
+$38.2M
4
ETR icon
Entergy
ETR
+$30.6M
5
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$27.9M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$378M
2
AMZN icon
Amazon
AMZN
+$336M
3
AAPL icon
Apple
AAPL
+$294M
4
BABA icon
Alibaba
BABA
+$258M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$136M

Sector Composition

Rank Sector Weight
1 Technology 12.92%
2 Consumer Discretionary 8.02%
3 Utilities 7.46%
4 Healthcare 7.42%
5 Financials 7.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARKG icon
2101
PUT
ARK Genomic Revolution ETF
ARKG
$1.89B
– –
-60,000
Closed -$5.6M
ARKK icon
2102
ARK Innovation ETF
ARKK
$6.44B
– –
-100,000
Closed -$12.4M
ASHR icon
2103
CALL
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.55B
– –
-48,000
Closed -$1.92M
ASHR icon
2104
PUT
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.55B
– –
-40,000
Closed -$1.6M
LONA
2105
LeonaBio Inc
LONA
$72.9M
– –
-770
Closed -$264K
ATNM icon
2106
Actinium Pharmaceuticals
ATNM
$33.3M
– –
-11,900
Closed -$93K
ATO icon
2107
Atmos Energy
ATO
$28.3B
– –
-42,648
Closed -$4.07M
ATRA icon
2108
Atara Biotherapeutics
ATRA
$95.2M
– –
-1,110
Closed -$545K
ATRO icon
2109
Astronics
ATRO
$3.24B
– –
-20,678
Closed -$228K
OPTU
2110
PUT
Optimum Communications Inc
OPTU
$330M
– –
-180,000
Closed -$6.82M
ATXS
2111
DELISTED
Astria Therapeutics
ATXS
– –
-1,998
Closed -$26K
AVTR icon
2112
Avantor
AVTR
$9.63B
– –
-44,001
Closed -$1.24M
AVY icon
2113
Avery Dennison
AVY
$13.9B
– –
-3,400
Closed -$527K
AWK icon
2114
American Water Works
AWK
$27.7B
– –
-23,389
Closed -$3.59M
AZN icon
2115
AstraZeneca
AZN
$258B
– –
-8,406
Closed -$840K
BABA icon
2116
Alibaba
BABA
$284B
– –
-1,048,535
Closed -$258M
BAX icon
2117
CALL
Baxter International
BAX
$13.6B
– –
-50,000
Closed -$4.01M
BBVA icon
2118
Banco Bilbao Vizcaya Argentaria
BBVA
$161B
– –
-56,125
Closed -$277K
BCAB icon
2119
BioAtla
BCAB
$5.56M
– –
-357
Closed -$608K
BCS icon
2120
Barclays
BCS
$90.9B
– –
-41,111
Closed -$328K
BDN
2121
Brandywine Realty Trust
BDN
$548M
– –
-25,200
Closed -$300K
BDSX icon
2122
Biodesix
BDSX
$269M
– –
-1,951
Closed -$787K
BEAM icon
2123
Beam Therapeutics
BEAM
$2.95B
– –
-15,108
Closed -$1.23M
BBT
2124
Beacon Financial Corp
BBT
$2.66B
– –
-19,810
Closed -$339K
BJ icon
2125
BJs Wholesale Club
BJ
$12.7B
– –
-14,264
Closed -$532K
83 84
85
86 87

Similar funds

FGP
Freestone Grove Partners San Francisco, California $15.6B AUM 27.39% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
AA
Acorns Advisers Irvine, California $15.3B AUM 18.32% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $15.8B AUM 1.29% 1-Year Est. Return
NMIFOAC
National Mutual Insurance Federation of Agricultural Cooperatives Tokyo, Japan, Japan $15.3B AUM 24.71% 1-Year Est. Return

Michael Gelband's Q1 2021 Portfolio in Review

As of Q1 2021, Michael Gelband held 2,871 positions worth $6.86B, down 33% from $10.3B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Michael Gelband withdrew a net $3.78B in Q1 2021, closing 811 positions and reducing 524 holdings. Its most notable exit was Alibaba, an estimated $258M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Utilities.

Against the trend, Michael Gelband opened a new position in Comcast worth $39.1M.

  • Michael Gelband's largest Q1 2021 buy was Comcast: 722,523 shares worth $39.1M.
  • Michael Gelband added most to iShares Russell 1000 Value ETF in Q1 2021, an estimated $48M increase.
  • Michael Gelband's biggest Q1 2021 reduction was Microsoft, cutting an estimated $378M.
  • Michael Gelband fully exited Alibaba in Q1 2021, selling an estimated $258M.
  • Michael Gelband's ten largest holdings make up 26% of its $6.86B portfolio in Q1 2021.
  • Michael Gelband opened 973 new positions and closed 811 in Q1 2021.
  • Michael Gelband's portfolio value fell 33% quarter-over-quarter to $6.86B.

Based on ExodusPoint Capital Management's 13F filing for Q1 2021, filed 17 May 2021.